NEJM Interview: Dr. Roy Perlis on esketamine as an option for treatment-resistant depression.
NEJM Interviews - Un pódcast de NEJM Group - Miercoles
Dr. Roy Perlis is the director of the Center for Quantitative Health at Massachusetts General Hospital and a professor of psychiatry at Harvard Medical School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J. Kim and Others. Esketamine for Treatment-Resistant Depression — First FDA-Approved Antidepressant in a New Class. N Engl J Med 2019;381:1-4.
